Testing effectiveness (Phase 2)Study completedNCT00946270What this trial is testingPomalidomide for Myelofibrosis PatientsWho this might be right forPolycythemia VeraThrombocythemia M.D. Anderson Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT01259856What this trial is testingRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Who this might be right forHigh Risk Polycythemia VeraHigh Risk Essential Thrombocythemia Ronald Hoffman 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262141What this trial is testingIMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)Who this might be right forEssential ThrombocythemiaPolycythemia Vera Terrence J Bradley, MD 4
Testing effectiveness (Phase 2)Ended earlyNCT00720629What this trial is testingVisilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forGraft Versus Host Disease H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Not Yet RecruitingNCT07529951What this trial is testingStudy of ZE74-0282 for Patients With JAK2 V617F Positive Blood CancersWho this might be right forPolycythemia Vera (PV)Myelofibrosis (MF) Eilean Therapeutics 60
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT02169791What this trial is testingNonmyeloablative Haploidentical Transplant Followed by MLN9708Who this might be right forAcute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more Northside Hospital, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT02007811What this trial is testingOpen-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more University of Erlangen-Nürnberg Medical School 15
Testing effectiveness (Phase 2)Study completedNCT00509899What this trial is testingOpen Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisWho this might be right forMyelofibrosisPolycythemia VeraThrombocytosis Incyte Corporation 154
Testing effectiveness (Phase 2)Looking for participantsNCT05807932What this trial is testingVenetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAMLWho this might be right forMyelodysplastic SyndromesSecondary Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia Heinrich-Heine University, Duesseldorf 38
Early research (Phase 1)Study completedNCT04439006What this trial is testingIbrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationWho this might be right forAplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more Jennifer Woyach 10
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Very early researchLooking for participantsNCT03964506What this trial is testingHyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+4 more Omar Aljitawi 24
Early research (Phase 1)Study completedNCT02167958What this trial is testingNonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceWho this might be right forLeukemiaMDSMyelofibrosis+1 more Rafic Farah, MD 28
Testing effectiveness (Phase 2)Study completedNCT01901432What this trial is testingA Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Italfarmaco 48
Testing effectiveness (Phase 2)Study completedNCT00586651What this trial is testingOpen-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential ThrombocytosisWho this might be right forPolycythemia VeraEssential Thrombocytosis Cephalon 39
Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Large-scale testing (Phase 3)Active Not RecruitingNCT04285086What this trial is testingRopeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntoleranceWho this might be right forEssential Thrombocythemia PharmaEssentia 174